Endpoints News

The Peanut Butter Cup company put $200 million behind a treatment for peanut allergyhttps://endpts.com/the-peanut-butter-cup-company-put-200-million-behind-a-treatment-for-peanut-allergy/ …

Bill Gates pitches in on coronavirus R&D and containment efforts with $100M commitmenthttps://endpts.com/bill-gates-pitches-in-on-coronavirus-rd-and-containment-efforts-with-100m-commitment/ …

Active Biotech is back, with one last bid for the failed MS drug Teva discardedhttps://endpts.com/active-biotech-is-back-with-one-last-bid-for-the-failed-ms-drug-teva-discarded/ …

GlaxoSmithKline CEO Emma Walmsley is triggering a New GSK R&D makeover, while shedding dermatologyhttps://endpts.com/glaxosmithkline-ceo-emma-walmsley-is-triggering-a-new-gsk-rd-makeover-while-shedding-dermatology/ …

Leaner and meaner? Ken Frazier slims down Merck to fortify position in oncology, vaccineshttps://endpts.com/leaner-and-meaner-ken-frazier-slims-down-merck-to-fortify-position-in-oncology-vaccines/ …

China researchers tout in vitro data for Gilead's antiviral against Wuhan virus — which they are trying to patenthttps://endpts.com/china-researchers-tout-in-vitro-data-for-gileads-antiviral-against-wuhan-virus-which-they-are-trying-to-patent/ …

Yes, Gilead CEO Daniel O’Day is ready to ink some deals. No, you won’t see him sweat ithttps://endpts.com/yes-gilead-ceo-daniel-oday-is-ready-to-ink-some-deals-no-you-wont-see-him-sweat-it/ …

French cancer-focused microbiome player is flush with €18M Series B injectionhttps://endpts.com/french-cancer-focused-microbiome-player-is-flush-with-e18m-series-b-injection/ …

#HIV vaccine remains Holy Grail as Sanofi/GSK regimen disappoints in large study https://endpts.com/hiv-vaccine-remains-holy-grail-as-sanofi-gsk-regimen-disappoints-in-large-study/ … $SNY $GSK

#BioMotiv, Bristol-Myers alliance bears fruit with new company: Anteros Pharma https://endpts.com/biomotiv-bristol-myers-alliance-bears-fruit-with-new-company-anteros-pharma/ … $BMY

Regeneron joins the hunt for antibodies to fight a brewing pandemic as researchers whip up new trials for antivirals https://endpts.com/regeneron-joins-the-hunt-for-antibodies-to-fight-a-brewing-pandemic-as-researchers-whip-up-new-trials-for-antivirals/ … $REGN

Too slow to warn: Sanofi indicted over old anti-epileptic drug tied to birth defects — reports https://endpts.com/too-slow-to-warn-sanofi-indicted-over-old-anti-epileptic-drug-tied-to-birth-defects-reports/ … $SNY

Q&A with Jorge Conde as Andreessen Horowitz launches $750M bio fund III https://endpts.com/qa-with-jorge-conde-as-andreessen-horowitz-launches-750m-bio-fund-iii/ … #andreessenhorowitz

Insmed’s PhII smokes and sputters, but researchers herald enough surprisingly positive data to roar on Wall Street https://endpts.com/insmeds-phii-smokes-and-sputters-but-researchers-herald-enough-surprisingly-positive-data-to-roar-on-wall-street/ … $INSM

F-Prime backs a niche #AI software startup hunting lofty goals in $22M Series Bhttps://endpts.com/f-prime-backs-a-niche-ai-software-startup-hunting-lofty-goals-in-22m-series-b/ …

The Sanofi-partnered startup finding clinical trials for the 90%https://endpts.com/the-sanofi-partnered-startup-finding-clinical-trials-for-the-90/ …

HIV vaccine remains Holy Grail as Sanofi/GSK regimen disappoints in large studyhttps://endpts.com/hiv-vaccine-remains-holy-grail-as-sanofi-gsk-regimen-disappoints-in-large-study/ …

BioMotiv, Bristol-Myers alliance bears fruit with new company: Anteros Pharmahttps://endpts.com/biomotiv-bristol-myers-alliance-bears-fruit-with-new-company-anteros-pharma/ …

Regeneron joins the hunt for antibodies to fight a brewing pandemic as researchers whip up new trials for antiviralshttps://endpts.com/regeneron-joins-the-hunt-for-antibodies-to-fight-a-brewing-pandemic-as-researchers-whip-up-new-trials-for-antivirals/ …

Too slow to warn: Sanofi indicted over old anti-epileptic drug tied to birth defects — reportshttps://endpts.com/too-slow-to-warn-sanofi-indicted-over-old-anti-epileptic-drug-tied-to-birth-defects-reports/ …